Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Qualitative and quantitative changes in the oral bacterial flora occur shortly after implementation of fixed orthodontic appliances.

Reichardt E, Geraci J, Sachse S, Rödel J, Pfister W, Löffler B, Wagner Y, Eigenthaler M, Wolf M.

Am J Orthod Dentofacial Orthop. 2019 Dec;156(6):735-744. doi: 10.1016/j.ajodo.2018.12.018.

PMID:
31784007
2.

Bactericidal and Biocompatible Properties of Plasma Chemical Oxidized Titanium (TiOB®) with Antimicrobial Surface Functionalization.

Kranz S, Guellmar A, Voelpel A, Lesser T, Tonndorf-Martini S, Schmidt J, Schrader C, Faucon M, Finger U, Pfister W, Diefenbeck M, Sigusch B.

Materials (Basel). 2019 Mar 15;12(6). pii: E866. doi: 10.3390/ma12060866.

3.

Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.

Rödel J, Mellmann A, Stein C, Alexi M, Kipp F, Edel B, Dawczynski K, Brandt C, Seidel L, Pfister W, Löffler B, Straube E.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):581-591. doi: 10.1007/s10096-018-03462-2. Epub 2019 Jan 24.

PMID:
30680577
4.

Naso- and oropharyngeal bacterial carriage in nursing home residents: Impact of multimorbidity and functional impairment.

Kwetkat A, Pfister W, Pansow D, Pletz MW, Sieber CC, Hoyer H.

PLoS One. 2018 Jan 5;13(1):e0190716. doi: 10.1371/journal.pone.0190716. eCollection 2018.

5.

Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study.

Forstner C, Kwetkat A, Makarewicz O, Hartung A, Pfister W, Fünfstück R, Hummers-Pradier E, Naber KG, Hagel S, Harrison N, Schumacher U, Pletz MW.

Clin Microbiol Infect. 2018 Apr;24(4):434-435. doi: 10.1016/j.cmi.2017.11.007. Epub 2017 Nov 10. No abstract available.

6.

Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline.

Sobke A, Makarewicz O, Baier M, Bär C, Pfister W, Gatermann SG, Pletz MW, Forstner C.

Int J Antimicrob Agents. 2018 Feb;51(2):213-220. doi: 10.1016/j.ijantimicag.2017.10.010. Epub 2017 Oct 27.

PMID:
29111434
7.

Acute diarrhoea due to a Shiga toxin 2e-producing Escherichia coli O8 : H19.

Saupe A, Edel B, Pfister W, Löffler B, Ehricht R, Rödel J.

JMM Case Rep. 2017 Jun 14;4(6):e005099. doi: 10.1099/jmmcr.0.005099. eCollection 2017 Jun.

8.

[Influence of nosocomial infections on activities of daily living in acute geriatric inpatients].

Marzahn D, Pfister W, Kwetkat A.

Z Gerontol Geriatr. 2018 Jun;51(4):440-445. doi: 10.1007/s00391-017-1310-7. Epub 2017 Sep 27. German.

PMID:
28956138
9.

On-chip spectroscopic assessment of microbial susceptibility to antibiotics within 3.5 hours.

Schröder UC, Kirchhoff J, Hübner U, Mayer G, Glaser U, Henkel T, Pfister W, Fritzsche W, Popp J, Neugebauer U.

J Biophotonics. 2017 Nov;10(11):1547-1557. doi: 10.1002/jbio.201600316. Epub 2017 May 2.

PMID:
28464521
10.

Evaluation of loop-mediated isothermal amplification for the rapid identification of bacteria and resistance determinants in positive blood cultures.

Rödel J, Bohnert JA, Stoll S, Wassill L, Edel B, Karrasch M, Löffler B, Pfister W.

Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):1033-1040. doi: 10.1007/s10096-016-2888-1. Epub 2017 Jan 6.

PMID:
28063000
11.

Does medical education predispose to risk behaviour during travel?

Schleenvoigt BT, Zahlten A, Loebermann M, Seidel T, Pfister W, Pletz MW.

Travel Med Infect Dis. 2017 Jan - Feb;15:74-75. doi: 10.1016/j.tmaid.2016.10.010. Epub 2016 Oct 26. No abstract available.

PMID:
27794474
12.

Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.

Janhsen WK, Arnold C, Hentschel J, Lehmann T, Pfister W, Baier M, Böer K, Hünniger K, Kurzai O, Hipler UC, Mainz JG.

Med Microbiol Immunol. 2016 Oct;205(5):485-500. doi: 10.1007/s00430-016-0463-0. Epub 2016 Jul 4.

PMID:
27377929
13.

Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats.

Diefenbeck M, Schrader C, Gras F, Mückley T, Schmidt J, Zankovych S, Bossert J, Jandt KD, Völpel A, Sigusch BW, Schubert H, Bischoff S, Pfister W, Edel B, Faucon M, Finger U.

Biomaterials. 2016 Sep;101:156-64. doi: 10.1016/j.biomaterials.2016.05.039. Epub 2016 Jun 2.

PMID:
27294535
14.

Health problems and behavioural risks in travellers to the tropics - A commentary.

Schleenvoigt BT, Zahlten A, Loebermann M, Seidel T, Pfister W, Pletz MW.

Travel Med Infect Dis. 2016 May-Jun;14(3):279-80. doi: 10.1016/j.tmaid.2016.04.003. Epub 2016 Apr 14. No abstract available.

PMID:
27094765
15.

Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus.

Walther E, Xu Z, Richter M, Kirchmair J, Grienke U, Rollinger JM, Krumbholz A, Saluz HP, Pfister W, Sauerbrei A, Schmidtke M.

Front Microbiol. 2016 Mar 21;7:357. doi: 10.3389/fmicb.2016.00357. eCollection 2016.

16.

Antibiotic treatment algorithm development based on a microarray nucleic acid assay for rapid bacterial identification and resistance determination from positive blood cultures.

Rödel J, Karrasch M, Edel B, Stoll S, Bohnert J, Löffler B, Saupe A, Pfister W.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):252-7. doi: 10.1016/j.diagmicrobio.2015.10.021. Epub 2015 Nov 14.

PMID:
26712265
17.

Reduced effect of intravenous antibiotic treatment on sinonasal markers in pulmonary inflammation.

Doht F, Hentschel J, Fischer N, Lehmann T, Markert UR, Böer K, Pfister W, Pletz MW, Guntinas-Lichius O, Mainz JG.

Rhinology. 2015 Sep;53(3):249-59. doi: 10.4193/Rhin14.300.

PMID:
26363166
18.

Rapid, culture-independent, optical diagnostics of centrifugally captured bacteria from urine samples.

Schröder UC, Bokeloh F, O'Sullivan M, Glaser U, Wolf K, Pfister W, Popp J, Ducrée J, Neugebauer U.

Biomicrofluidics. 2015 Aug 11;9(4):044118. doi: 10.1063/1.4928070. eCollection 2015 Jul.

19.

Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy.

Assmann C, Kirchhoff J, Beleites C, Hey J, Kostudis S, Pfister W, Schlattmann P, Popp J, Neugebauer U.

Anal Bioanal Chem. 2015 Nov;407(27):8343-52. doi: 10.1007/s00216-015-8912-y. Epub 2015 Aug 1.

PMID:
26231687
20.

Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.

Müller U, Hentschel J, Janhsen WK, Hünniger K, Hipler UC, Sonnemann J, Pfister W, Böer K, Lehmann T, Mainz JG.

Mediators Inflamm. 2015;2015:626530. doi: 10.1155/2015/626530. Epub 2015 Jun 21.

21.

Investigation of bacterial translocation in chronic ischemic heart failure in the rat.

Betge S, Stingl M, Pfister W, Figulla HR, Jung C.

Clin Lab. 2015;61(1-2):93-100.

PMID:
25807643
22.

[Cerebrospinal fluid analysis-based diagnosis in neuroinfections: an update].

Dieterich M, Pfister W.

Fortschr Neurol Psychiatr. 2015 Feb;83(2):73. doi: 10.1055/s-0034-1399017. Epub 2015 Feb 27. German. No abstract available.

PMID:
25723770
23.

Detection of vancomycin resistances in enterococci within 3 ½ hours.

Schröder UC, Beleites C, Assmann C, Glaser U, Hübner U, Pfister W, Fritzsche W, Popp J, Neugebauer U.

Sci Rep. 2015 Feb 3;5:8217. doi: 10.1038/srep08217.

24.

Antipneumococcal activity of neuraminidase inhibiting artocarpin.

Walther E, Richter M, Xu Z, Kramer C, von Grafenstein S, Kirchmair J, Grienke U, Rollinger JM, Liedl KR, Slevogt H, Sauerbrei A, Saluz HP, Pfister W, Schmidtke M.

Int J Med Microbiol. 2015 May;305(3):289-97. doi: 10.1016/j.ijmm.2014.12.004. Epub 2014 Dec 18.

25.

Structured inquiry-based learning: Drosophila GAL4 enhancer trap characterization in an undergraduate laboratory course.

Dunne CR, Cillo AR, Glick DR, John K, Johnson C, Kanwal J, Malik BT, Mammano K, Petrovic S, Pfister W, Rascoe AS, Schrom D, Shapiro S, Simkins JW, Strauss D, Talai R, Tomtishen JP 3rd, Vargas J, Veloz T, Vogler TO, Clenshaw ME, Gordon-Hamm DT, Lee KL, Marin EC.

PLoS Biol. 2014 Dec 30;12(12):e1002030. doi: 10.1371/journal.pbio.1002030. eCollection 2014 Dec.

26.

Toward culture-free Raman spectroscopic identification of pathogens in ascitic fluid.

Kloß S, Rösch P, Pfister W, Kiehntopf M, Popp J.

Anal Chem. 2015 Jan 20;87(2):937-43. doi: 10.1021/ac503373r. Epub 2014 Dec 30.

PMID:
25517827
27.

Ovarian vein thrombosis (OVT) following invasive group A Streptococcus (iGAS) puerperal sepsis associated with expression of streptococcal pyrogenic exotoxin genes speC, speG and speJ.

Karrasch M, Rödel J, Mühler N, Edel B, Sachse S, Schmidt KH, Schneider U, Schlembach D, Mentzel HJ, Pfister W, Schleußner E.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:127-30. doi: 10.1016/j.ejogrb.2014.11.019. Epub 2014 Nov 24. No abstract available.

PMID:
25480103
28.

Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.

Hentschel J, Fischer N, Janhsen WK, Markert UR, Lehmann T, Sonnemann J, Böer K, Pfister W, Hipler UC, Mainz JG.

J Cyst Fibros. 2015 May;14(3):324-33. doi: 10.1016/j.jcf.2014.09.003. Epub 2014 Oct 5.

29.

Comparison of multilocus sequence typing, RAPD, and MALDI-TOF mass spectrometry for typing of β-lactam-resistant Klebsiella pneumoniae strains.

Sachse S, Bresan S, Erhard M, Edel B, Pfister W, Saupe A, Rödel J.

Diagn Microbiol Infect Dis. 2014 Dec;80(4):267-71. doi: 10.1016/j.diagmicrobio.2014.09.005. Epub 2014 Sep 16.

PMID:
25266674
30.

Primary Epstein-Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis.

Karrasch M, Felber J, Keller PM, Kletta C, Egerer R, Bohnert J, Hermann B, Pfister W, Theis B, Petersen I, Stallmach A, Baier M.

Int J Infect Dis. 2014 Nov;28:143-6. doi: 10.1016/j.ijid.2014.08.003. Epub 2014 Sep 19.

31.

Placental Schistosoma haematobium infection in a German returnee from Malawi.

Schleenvoigt BT, Gajda M, Baier M, Groten T, Oppel-Heuchel H, Grimm MO, Pfister W, Richter J, Pletz MW.

Infection. 2014 Dec;42(6):1061-4. doi: 10.1007/s15010-014-0684-3. Epub 2014 Sep 19.

PMID:
25234200
32.

Honey - a potential agent against Porphyromonas gingivalis: an in vitro study.

Eick S, Schäfer G, Kwieciński J, Atrott J, Henle T, Pfister W.

BMC Oral Health. 2014 Mar 25;14:24. doi: 10.1186/1472-6831-14-24.

33.

Oral prophylaxis and its effects on halitosis-associated and inflammatory parameters in patients with chronic periodontitis.

Guentsch A, Pfister W, Cachovan G, Raschke G, Kuepper H, Schaefer O, Eick S.

Int J Dent Hyg. 2014 Aug;12(3):199-207. doi: 10.1111/idh.12063. Epub 2013 Dec 7.

PMID:
24314016
34.

Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.

Wagenlehner FM, Münch F, Pilatz A, Bärmann B, Weidner W, Wagenlehner CM, Straubinger M, Blenk H, Pfister W, Kresken M, Naber KG.

Antimicrob Agents Chemother. 2014;58(2):713-21. doi: 10.1128/AAC.02147-13. Epub 2013 Nov 11.

35.

Combined dielectrophoresis-Raman setup for the classification of pathogens recovered from the urinary tract.

Schröder UC, Ramoji A, Glaser U, Sachse S, Leiterer C, Csaki A, Hübner U, Fritzsche W, Pfister W, Bauer M, Popp J, Neugebauer U.

Anal Chem. 2013 Nov 19;85(22):10717-24. doi: 10.1021/ac4021616. Epub 2013 Nov 6.

PMID:
24125497
36.

Culture independent Raman spectroscopic identification of urinary tract infection pathogens: a proof of principle study.

Kloss S, Kampe B, Sachse S, Rösch P, Straube E, Pfister W, Kiehntopf M, Popp J.

Anal Chem. 2013 Oct 15;85(20):9610-6. doi: 10.1021/ac401806f. Epub 2013 Sep 24.

PMID:
24010860
37.

Comparative antibacterial efficacies of hydrodynamic and ultrasonic irrigation systems in vitro.

Cachovan G, Schiffner U, Altenhof S, Guentsch A, Pfister W, Eick S.

J Endod. 2013 Sep;39(9):1171-5. doi: 10.1016/j.joen.2013.06.008.

PMID:
23953293
38.

[Endogenous malassezia endophthalmitis].

Augsten R, Pfister W, Wildner K, Voigt U, Oelzner P, Königsdörffer E.

Klin Monbl Augenheilkd. 2013 May;230(5):536-7. doi: 10.1055/s-0032-1328420. Epub 2013 May 21. German. No abstract available.

PMID:
23695851
39.

Antibacterial effect of different root canal sealers on three bacterial species.

Heyder M, Kranz S, Völpel A, Pfister W, Watts DC, Jandt KD, Sigusch BW.

Dent Mater. 2013 May;29(5):542-9. doi: 10.1016/j.dental.2013.02.007. Epub 2013 Mar 22.

PMID:
23523285
40.

Benzamidine derivatives inhibit the virulence of Porphyromonas gingivalis.

Fröhlich E, Kantyka T, Plaza K, Schmidt KH, Pfister W, Potempa J, Eick S.

Mol Oral Microbiol. 2013 Jun;28(3):192-203. doi: 10.1111/omi.12015. Epub 2012 Dec 26.

41.

Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

Guentsch A, Hirsch C, Pfister W, Vincents B, Abrahamson M, Sroka A, Potempa J, Eick S.

J Periodontal Res. 2013 Aug;48(4):458-65. doi: 10.1111/jre.12027. Epub 2012 Nov 1.

42.

Hyaluronic Acid as an adjunct after scaling and root planing: a prospective randomized clinical trial.

Eick S, Renatus A, Heinicke M, Pfister W, Stratul SI, Jentsch H.

J Periodontol. 2013 Jul;84(7):941-9. doi: 10.1902/jop.2012.120269. Epub 2012 Oct 22.

PMID:
23088524
43.

Variables of host response in saliva of patients with periodontitis: a pilot study.

Guentsch A, Hiese I, Puklo M, Kiehntopf M, Pfister W, Eick S.

Quintessence Int. 2012 Sep;43(8):e104-14.

PMID:
23034426
44.

Soluble inflammation markers in nasal lavage from CF patients and healthy controls.

Beiersdorf N, Schien M, Hentschel J, Pfister W, Markert UR, Mainz JG.

J Cyst Fibros. 2013 May;12(3):249-57. doi: 10.1016/j.jcf.2012.08.015. Epub 2012 Sep 16.

45.

The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc.

Sobke A, Klinger M, Hermann B, Sachse S, Nietzsche S, Makarewicz O, Keller PM, Pfister W, Straube E.

Antimicrob Agents Chemother. 2012 Nov;56(11):6021-5. doi: 10.1128/AAC.01484-12. Epub 2012 Aug 27.

46.

Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.

Reuken PA, Pletz MW, Baier M, Pfister W, Stallmach A, Bruns T.

Aliment Pharmacol Ther. 2012 May;35(10):1199-208. doi: 10.1111/j.1365-2036.2012.05076.x. Epub 2012 Mar 26.

47.

Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study.

Simon TP, Schuerholz T, Hüter L, Sasse M, Heyder F, Pfister W, Marx G.

Crit Care. 2012 Jan 25;16(1):R16. doi: 10.1186/cc11161.

48.

Characterization of Aggregatibacter actinomycetemcomitans strains in periodontitis patients in Germany.

Jentsch H, Cachovan G, Guentsch A, Eickholz P, Pfister W, Eick S.

Clin Oral Investig. 2012 Dec;16(6):1589-97. doi: 10.1007/s00784-012-0672-x. Epub 2012 Jan 14.

PMID:
22246112
49.

Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid.

Laugisch O, Schacht M, Guentsch A, Kantyka T, Sroka A, Stennicke HR, Pfister W, Sculean A, Potempa J, Eick S.

Mol Oral Microbiol. 2012 Feb;27(1):45-56. doi: 10.1111/j.2041-1014.2011.00631.x. Epub 2011 Dec 7.

50.

Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation.

Mainz JG, Hentschel J, Schien C, Cramer N, Pfister W, Beck JF, Tümmler B.

J Cyst Fibros. 2012 Mar;11(2):158-61. doi: 10.1016/j.jcf.2011.10.009. Epub 2011 Nov 30.

Supplemental Content

Loading ...
Support Center